Neonc Technologies Holdings, Inc. (NASDAQ:NTHI – Get Free Report) CMO Thomas Chen bought 2,284 shares of Neonc Technologies stock in a transaction dated Tuesday, November 10th. The shares were purchased at an average cost of $4.38 per share, for a total transaction of $10,003.92. Following the completion of the transaction, the chief marketing officer owned 29,519 shares of the company’s stock, valued at approximately $129,293.22. This represents a 8.39% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
Neonc Technologies Stock Up 3.4%
NTHI opened at $4.52 on Thursday. The company has a fifty day simple moving average of $3.30 and a 200 day simple moving average of $5.31. Neonc Technologies Holdings, Inc. has a twelve month low of $2.50 and a twelve month high of $12.00.
Neonc Technologies (NASDAQ:NTHI – Get Free Report) last released its quarterly earnings results on Thursday, November 5th. The company reported ($0.28) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.25) by ($0.03).
Wall Street Analyst Weigh In
NTHI has been the topic of several recent analyst reports. BTIG Research reiterated a “buy” rating and issued a $15.00 price target on shares of Neonc Technologies in a research note on Tuesday, September 8th. Weiss Ratings lowered Neonc Technologies from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Wednesday, October 21st. Wall Street Zen upgraded Neonc Technologies from a “sell” rating to a “hold” rating in a report on Saturday, November 7th. Zacks Research raised Neonc Technologies from a “strong sell” rating to a “hold” rating in a research report on Thursday, November 5th. Finally, Roth Capital assumed coverage on Neonc Technologies in a research note on Thursday, September 24th. They set a “buy” rating for the company. Four investment analysts have rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $16.00.
Check Out Our Latest Analysis on NTHI
Hedge Funds Weigh In On Neonc Technologies
A number of hedge funds have recently bought and sold shares of NTHI. Global Retirement Partners LLC bought a new stake in Neonc Technologies in the second quarter valued at about $126,000. BlackRock Inc. bought a new position in Neonc Technologies during the 2nd quarter worth approximately $815,000. Westmount Partners LLC lifted its holdings in Neonc Technologies by 355.2% during the 2nd quarter. Westmount Partners LLC now owns 197,178 shares of the company’s stock worth $893,000 after buying an additional 153,858 shares during the last quarter. Finally, Bank of America Corp DE acquired a new position in shares of Neonc Technologies in the 2nd quarter worth approximately $1,017,000.
Neonc Technologies Company Profile
NeOnc Technologies Holdings, Inc. is a biotechnology company developing treatments for brain tumors and other central nervous system cancers. Its research focuses on approaches intended to deliver therapies to the brain, where the blood-brain barrier can limit the effectiveness of conventional treatments. The company’s pipeline includes NEO100, a formulation of perillyl alcohol designed for intranasal delivery, and NEO212, a compound combining perillyl alcohol with temozolomide. These candidates are being developed for potential use in brain cancer treatment.
Read More
- Five stocks we like better than Neonc Technologies
- Keeping AI Cool: AAON Rides the AI Heatwave to Record Growth
- AST SpaceMobile Has a New Rocket Plan, But Its Cash-Burn Problem Isn’t Going Away
- Powering Up the Moon: Redwire’s $40 Million NASA Award
- Can Constellation Energy’s Contracts Power a Stock Rebound?
Receive News & Ratings for Neonc Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Neonc Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
